Our company develops innovative materials in different fields. Currently we are focusing on the development and production of anodic materials for LTO batteries. We have a laboratory embedded in the University of Turin (Italy) with full equipments to characterise and synthesise.
Our Technology Offers
Anode Material for Li-ion Batteries and Supercapacitors
Lithium-ion batteries plays an important role in our daily life thanks to their excellent rechargeability and adequate power and energy densities. A key material that has enable this success is graphite, which serve as a lithium-ion host structure for the negative electrode (anode). Despite numerous research and development efforts to find suitable alternatives with enhanced power and energy density, while maintaining the cycling stability, graphite is still used in the vast majority of commercially available lithium-ion batteries as it is relatively low cost, and is generally compatible with various cathode chemistries.
Based in Italy, the technology owner has proposed a novel anode compound made of alloyed lithium-aluminium-zinc-titanium oxide (LAZTO) materials, with the aim to boost the power and energy density of lithium titanium oxide (LTO) batteries commonly found in fast charge stations or applications that require long cycle life. When paired with lithium iron phosphate (LFP) or lithium manganese oxide (LMO) cathodes, the anode compound has the potential to deliver higher discharge rate capability and good cycling stability compared to conventional LTO chemistry.
The improved LTO chemistry is expected to achieve more than 20,000 cycles and is capable to recharge within 6-10 minutes, with a recharge efficiency of more than 98%. The anode material is in the form of micronized powder and may be applicable for use in cells with different cathodes such as lithium nickel manganese cobalt (NMC) oxide or supercapacitors. The technology owner is seeking industry partners such as battery manufacturers to collaborate through various R&D projects, as well as business partnerships and co-investment to develop cells in different formats with locations in either Singapore or Turin, Italy.